HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Icatibant blocks but does not reverse ACE inhibitor renal effect in Goldblatt rabbit.

Abstract
This study examined the proposition that kinins are involved in the renal hemodynamic effect of an ACE inhibitor in Goldblatt (GB) hypertension. The effects of the ACE inhibitor enalaprilat were compared in two groups of anesthetized two-kidney one-clip GB rabbits. One group (n = 11) was given enalaprilat (10 mg/kg, i.v.) while a second group (n = 10) received the kinin B2 receptor antagonist, icatibant (2.5-5 microg/kg/min, i.v.) prior to enalaprilat. Enalaprilat caused a 40% rise in renal blood flow and 11 mm Hg decrease in blood pressure in the untreated, but no significant renal effect in the icatibant-treated group. Blood pressure was reduced to the same degree in both groups. The results indicate that kinins play a major role in the renal hemodynamic, but not the blood pressure effect of ACE inhibition in the GB rabbit.
AuthorsBen G Zimmerman
JournalClinical and experimental hypertension (New York, N.Y. : 1993) (Clin Exp Hypertens) Vol. 24 Issue 5 Pg. 325-32 (Jul 2002) ISSN: 1064-1963 [Print] England
PMID12109773 (Publication Type: Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Bradykinin Receptor Antagonists
  • Receptor, Bradykinin B2
  • icatibant
  • Kallikreins
  • Enalaprilat
  • Bradykinin
Topics
  • Adrenergic beta-Antagonists (pharmacology)
  • Angiotensin-Converting Enzyme Inhibitors (pharmacology)
  • Animals
  • Blood Pressure (drug effects)
  • Bradykinin (analogs & derivatives, pharmacology)
  • Bradykinin Receptor Antagonists
  • Drug Interactions
  • Enalaprilat (pharmacology)
  • Hypertension, Renal (drug therapy, pathology)
  • Kallikreins (physiology)
  • Kidney (blood supply, pathology)
  • Organ Size
  • Rabbits
  • Receptor, Bradykinin B2
  • Renal Circulation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: